The female hormone megestrol acetate (MA) improves appetite and is associated with slight weight gain in patients with cancer, AIDS, and other underlying pathology, but comes with significant adverse events.
The FDA has approved an application to market the emergency contraceptive Plan B One-Step for use without a prescription by women 15 years of age and older.
The use of a postoperative levonorgestrel-releasing intrauterine device reduces the recurrence of painful periods in women with endometriosis.
Women with endometriosis who undergo surgery to treat the condition are less likely to have ovarian cancer develop later in life.
Plan B and other levonorgestrel-based emergency contraception will be available over-the-counter without age restrictions.
Immediate start of hormonal contraception may reduce unintended pregnancies and increase method continuation, but the evidence is limited, according to the findings of an intervention review conducted by the Cochrane Fertility Regulation Group.
Women who have migraine with aura, especially those who take combined hormonal contraceptives (CHCs) have an increased risk for cardiovascular or thrombotic events.
Evaluation of a patient’s lipid profile before prescribing a combined oral contraceptive could be justified by the high prevalence of dyslipidemia, concludes a new study.
Women with polycystic ovary syndrome who take combined oral contraceptives are more than twice as likely as women without PCOS who take oral contraceptives to have a venous thromboembolism (VTE), according to the findings of a new study.
Topical or intracervical 2% lidocaine gel applied before intrauterine device (IUD) insertion does not decrease pain scores, but there are other ways to lessen discomfort.